Interstitial Lung Disease

Acceleron Pharma Inc announced that Habib Dable, Acceleron’s President and Chief Executive Officer, will present a corporate overview during the 39th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 11 at 10:00 a.m. EST, in a virtual format.

A live webcast of the presentation will be accessible under “Events and Presentations” in the Investors & Media page of the Company's website at …

View Conference Coverage

Take a look at some of our conference coverage, visit our roundup section.

Conference Roundup

  1. Jan 05, 2021

Acceleron to participate in the 39th Annual J.P. Morgan Healthcare Conference

Acceleron Pharma Inc announced that Habib Dable, Acceleron’s President and Chief Executive Officer, will present a corporate overview during the 39th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 11 at 10:00 a.m. EST, in a virtual format.

A…

Journal Scan

  1. Jan 04, 2021

Baseline pulmonary function tests help determine survival in ILD without pulmonary hypertension

Baseline pulmonary function tests may help determine mortality risk in patients with interstitial lung disease (ILD) without pulmonary hypertension (PH), according to a study.

In this study, 169 consecutive patients with ILD who underwent right heart catheterization were analyzed for…